Cleveland Clinic specialists across multiple disciplines are working to speed the diagnosis of immunoglobulin G4-related disease (IgG4-RD), a rare…
Articles by Steve Bryson PhD
Long-term use of the approved infusion therapy Uplizna (inebilizumab) leads to lasting cuts in flares, or periods of symptom…
A new imaging technique shows promise for assessing disease activity and organ involvement in immunoglobulin G4-related disease (IgG4-RD). Compared…
Four blood proteins may help diagnose immunoglobulin G4-related disease (IgG4-RD), monitor disease activity and treatment response, and predict relapse…
Researchers in Japan have described the clinical and tissue features of localized-type IgG4-related cholecystitis, a rare form of IgG4-related…
Obexelimab, Zenas Biopharma’s experimental, self-administered injectable therapy, reduced the risk of disease flares in adults with immunoglobulin G4-related…
The risk of developing cancer is more than four times higher in people with immunoglobulin G4-related disease (IgG4-RD) compared…
Nearly one in 10 people with immunoglobulin G4-related disease (IgG4-RD) also have at least one co-existing autoimmune disease, according…
People with the inflammatory condition IgG4-related disease (IgG4-RD) face a more severe form of illness when their pancreas is…
An advisory committee of the European Medicines Agency, or EMA — which evaluations medications for drug approval in the European…